Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology
-5.73% $26.51
Last updated: 3 jul 2022 - 19:51
TimeZone: America/New_York
FUNDAMENTALS | |
---|---|
MarketCap: | 1 062.54 mill |
EPS: | -1.161 |
P/E: | 0.000 |
Earnings Date: | Aug 01, 2022 |
SharesOutstanding: | 40.08 mill |
Avg Daily Volume: | 1.646 mill |
RATING 2022-07-01 |
---|
B+ |
Buy |
RATINGDETAILS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/20 | 1/21 | 2/21 | 3/21 | 4/21 | 1/22 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | ||||||
Asset | ||||||
Debt |
DISCOUNTED CASH FLOW VALUE |
---|
$32.43 (22.35%) $5.92 |
Date: 2022-07-03 |
True Range Average |
---|
+/- $2.56 ( +/- 9.65%) Range: 23.95 - 29.07 |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-06-06 | Barbier Remi | Sell | 65 368 | Common Stock |
2022-06-06 | Barbier Remi | Sell | 54 720 | Common Stock |
2022-06-06 | Barbier Remi | Buy | 65 368 | Common Stock |
2022-05-27 | Friedmann Nadav | Sell | 24 513 | Common Stock |
2022-05-27 | Friedmann Nadav | Sell | 21 498 | Common Stock |
INSIDER POWER |
---|
-12.86 |
Last 100 transactions |
Buy: 3 024 268 | Sell: 2 189 197 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $26.51 (-5.73% ) |
Volume | 0.757 mill |
Avg. Vol. | 1.646 mill |
% of Avg. Vol | 46.00 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since 31-12-69
Date | Signal | @ | Closed | % | Jun 28 - 16:58 | sell | $29.47 | N/A | Active |
---|